Hui Wang (Sophia)

Hui (Sophia) Wang is a seasoned pharmaceutical professional currently serving as the Head of Inhalation/Formulation Scientist at Insilico Medicine since August 2021. Prior experience includes a role as Project Manager at Livzon from September 2018 to August 2021, and a Research Fellow at Zhejiang University from October 2018 to December 2020. Hui's academic background features a postdoctoral researcher position at the University of Sydney from January 2017 to July 2018, and a Ph.D. candidacy at Queensland University of Technology from September 2013 to February 2017, focusing on the development of nanoparticles and inhalation devices for nicotine delivery. Hui's earlier career includes a brief tenure as a Medical Representative at Pfizer Inc. in 2013. Educational credentials include a Ph.D. in Medicinal and Pharmaceutical Chemistry with a focus on Nanotechnology from Queensland University of Technology, and a Bachelor’s Degree in Pharmacy from Central South University.